CAS: 219685-50-4 - Immunoglobulin,anti-(human complement C5 a-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide withhuman-mouse monoclonal 5G1.1 light chain, dimer (9CI)
- Synonyme:
- Eculizumab
- Soliris
- h5G1.1
- h5G1.1VHC+h5G1.1VLC
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Eculizumab REF: TM-T9915CAS: 219685-50-4 | 98.20% | 423,00 €~1.328,00 € | Fr 07 Jun 24 |
 | Eculizumab 10.0± 1.0mg/ml solution REF: 3D-BE165588CAS: 219685-50-4 | Min 95% | 857,00 €~1.613,00 € | Di 11 Jun 24 |
Eculizumab
CAS:219685-50-4
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5
Reinheit:
98.20%
Farbe und Form:
Solid
Molekulargewicht:
148 kDa
Ref: TM-T9915
| 1mg | 423,00 € | |
| 5mg | 984,00 € | |
| 10mg | 1.328,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 7. Juni 2024
Eculizumab 10.0± 1.0mg/ml solution
CAS:219685-50-4
Monoclonal antibody against complement protein C5
Reinheit:
Min 95%
Farbe und Form:
Powder
Ref: 3D-BE165588
| 1mg | 857,00 € | |
| 2mg | 1.130,00 € | |
| 5mg | 1.613,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 11. Juni 2024
